HBI Biotech Sciences is the leading & largest provider of preclinical research services in Israel.
With a dedicated team of experts and a commitment to excellence, we strive to advance scientific discoveries and support our clients in every step of the way.
For more information about our in vivo and in vitro services, please contact us at: 08-9409451 or send an email to;
HBI CEO Dr. Nati Ezov- nati.ezov@hbi-cro.com
HBI CSO Dr. Sheli Friedman- sheli.friedman@hbi-cro.com
HBI Administration- info@hbi-cro.com
Company Details
- Employees
- 8
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.hbi-cro.com
- Keywords
- In-Vivo Studies, In-Vitro Studies, Preclinical Toxicology, Preclinical Efficacy Studies, Biocompatibility for Medical Device, Batch Release (GMP), GLP & Non-GLP Studies, PK & TK Studies, Cell Therapy, Ex-Vivo, GLP Archive, Implantation, Health Monitoring for Laboratory Animals, Disease Models, Consulting Services, Biological Assays, Bioproduct, Cannabis, Gene Therapy.
Hbi Biotech Sciences Questions
Hbi Biotech Sciences's website is http://www.hbi-cro.com
Hbi Biotech Sciences's LinkedIn profile is https://www.linkedin.com/company/hbi-biotech-sciences
Hbi Biotech Sciences has
8 employees.
View email and phone details for 8
employees at Hbi Biotech Sciences.
Hbi Biotech Sciences's industry is
Biotechnology Research
Hbi Biotech Sciences's top competitors are
Profuse Technology,
Pre-Cure,
Lem Laboratory Of Pathology,
Kamada,
Baccine,
Vivox - Experts In Vivo,
Pharmaseed Ltd,
Omrix Biosurgery Israel,
Prilenia,
Mapi Pharma.
Hbi Biotech Sciences's categories are Biotechnology Research
Hbi Biotech Sciences's founding year is 1995
